IL128993A0 - A method for producing ecteinascidin compounds pharmaceutical compositions containing same and use thereof - Google Patents

A method for producing ecteinascidin compounds pharmaceutical compositions containing same and use thereof

Info

Publication number
IL128993A0
IL128993A0 IL12899397A IL12899397A IL128993A0 IL 128993 A0 IL128993 A0 IL 128993A0 IL 12899397 A IL12899397 A IL 12899397A IL 12899397 A IL12899397 A IL 12899397A IL 128993 A0 IL128993 A0 IL 128993A0
Authority
IL
Israel
Prior art keywords
ecteinascidin
pharmaceutical compositions
compositions containing
containing same
ecteinascidin compounds
Prior art date
Application number
IL12899397A
Other languages
English (en)
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of IL128993A0 publication Critical patent/IL128993A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL12899397A 1996-09-18 1997-09-17 A method for producing ecteinascidin compounds pharmaceutical compositions containing same and use thereof IL128993A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/715,541 US5721362A (en) 1996-09-18 1996-09-18 Process for producing ecteinascidin compounds
PCT/US1997/016470 WO1998012198A1 (en) 1996-09-18 1997-09-17 Process for producing ecteinascidin compounds

Publications (1)

Publication Number Publication Date
IL128993A0 true IL128993A0 (en) 2000-02-17

Family

ID=24874473

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12899397A IL128993A0 (en) 1996-09-18 1997-09-17 A method for producing ecteinascidin compounds pharmaceutical compositions containing same and use thereof
IL128993A IL128993A (en) 1996-09-18 1999-03-15 METHOD FOR PREPARING ACTINACIDIN COMPOUNDS 770 AND 743

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL128993A IL128993A (en) 1996-09-18 1999-03-15 METHOD FOR PREPARING ACTINACIDIN COMPOUNDS 770 AND 743

Country Status (21)

Country Link
US (1) US5721362A (cs)
EP (1) EP0931083B1 (cs)
JP (1) JP4425995B2 (cs)
KR (1) KR100358832B1 (cs)
CN (1) CN1096463C (cs)
AT (1) ATE232868T1 (cs)
AU (1) AU738282B2 (cs)
BR (1) BR9712073B1 (cs)
CA (1) CA2266081C (cs)
CZ (1) CZ299596B6 (cs)
DE (1) DE69719201T2 (cs)
DK (1) DK0931083T3 (cs)
ES (1) ES2192273T3 (cs)
HU (1) HU229407B1 (cs)
IL (2) IL128993A0 (cs)
NO (1) NO325345B1 (cs)
NZ (1) NZ334704A (cs)
PL (1) PL188572B1 (cs)
PT (1) PT931083E (cs)
RU (1) RU2194709C2 (cs)
WO (1) WO1998012198A1 (cs)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1067933B1 (en) * 1998-04-06 2007-08-15 The Board Of Trustees Of The University Of Illinois Semi-synthetic ecteinascidins
CA2331593C (en) * 1998-05-11 2008-08-05 Pharma Mar, S.A. Metabolites of ecteinascidin 743
US6124292A (en) 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
BG65893B1 (bg) * 1999-05-14 2010-04-30 Pharma Mar S.A. Полусинтетичен метод и нови съединения
AR035842A1 (es) * 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
GB9918178D0 (en) * 2000-05-15 1999-10-06 Pharma Mar Sa Synthetic methods
US6686470B2 (en) * 2000-01-19 2004-02-03 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
JP5102925B2 (ja) * 2000-02-11 2012-12-19 プレジデント アンド フェローズ オブ ハーバード カリッジ エクテインアシジン及びフタルアシジンのための中間体の合成方法
US6815544B2 (en) 2000-02-11 2004-11-09 President And Fellows Of Harvard College Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
US6569859B1 (en) 2000-02-22 2003-05-27 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
ES2244598T3 (es) * 2000-04-12 2005-12-16 Pharma Mar, S.A. Derivados antitumorales de ecteinascidina.
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US7420051B2 (en) * 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
NZ521808A (en) * 2000-05-15 2004-07-30 Pharma Mar S Synthetic process for the manufacture of an ecteinaschidin compound
US6809099B2 (en) 2000-11-03 2004-10-26 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
SK287901B6 (sk) * 2000-11-06 2012-03-02 Pharma Mar, S. A. Use of Ecteinascidin 743 for preparation of medicament for effective antitumor treatment
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
JP4208469B2 (ja) * 2002-01-29 2009-01-14 独立行政法人科学技術振興機構 エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
US7183054B2 (en) 2003-06-03 2007-02-27 President And Fellows Of Harvard College Assay for identifying biological targets of polynucleotide-binding compounds
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
PL1689404T3 (pl) * 2003-11-13 2009-02-27 Pharma Mar Sau Połączenie ET-743 z pro lekami 5-fluorouracylu do leczenia raka
US20080255132A1 (en) * 2003-11-14 2008-10-16 Eric Rowinsky Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
EP1768671A2 (en) * 2004-07-09 2007-04-04 Pharma Mar, S.A. Use of ecteinascidin in the treatment of cancer in patients with low level of brca1
CN100396178C (zh) * 2004-08-06 2008-06-25 中国科学院海洋研究所 一种玻璃海鞘的全人工养殖方法及简易型连续投饵装置
JP2008514688A (ja) * 2004-09-29 2008-05-08 ファルマ・マル・エス・アー， ソシエダッド・ユニペルソナル 抗炎症剤としてのエクテイナシジン化合物
SI1827500T1 (sl) * 2004-10-26 2009-10-31 Pharma Mar Sa Pegiliran liposomski doksorubicin v kombinaciji s ekteinescidinom 743
RS50510B (sr) 2004-10-29 2010-03-02 Pharma Mar S.A., Sociedad Unipersonal Formulacije koje sadrže ekteinascidin i disaharid
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CN101157929B (zh) * 2007-02-02 2012-05-23 中国科学院上海有机化学研究所 番红霉素的生物合成基因簇
AU2008313634A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Prognostic molecular markers for ET-743 treatment
EP2576569B1 (en) 2010-05-25 2015-01-14 Pharma Mar S.A. Synthetic process for the manufacture of ecteinascidin compounds and intermediates
CA2995033C (en) 2010-11-12 2020-04-28 Pharma Mar, S.A. Combination therapy with an antitumor alkaloid
CN103304478B (zh) * 2013-06-28 2016-04-20 四川大学 一类合成renieramycins型生物碱的中间体及其制备方法
CN104557850B (zh) * 2013-10-29 2019-07-30 江苏盛迪医药有限公司 一种海鞘碱-743中间体的制备方法
CN103709101B (zh) * 2013-12-19 2016-06-29 四川大学 一类renieramycin G的合成中间体及其制备方法
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN111518110B (zh) 2019-02-01 2023-11-03 博瑞生物医药（苏州）股份有限公司 一种海鞘素化合物及其中间体的制备方法
CN110092802B (zh) * 2019-06-21 2022-01-07 爱斯特（成都）生物制药股份有限公司 一种制备曲贝替定中间体的方法
US20220315605A1 (en) * 2019-06-27 2022-10-06 Msn Laboratories Private Limited, R&D Center IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OF
IL293128A (en) 2019-11-21 2022-07-01 Pharma Mar Sa Methods of treating small cell lung cancer with lurbinectedin formulations
CN114621245A (zh) * 2020-12-11 2022-06-14 江苏恒瑞医药股份有限公司 一种曲贝替定中间体的晶型及其制备方法
US12303506B2 (en) 2022-01-20 2025-05-20 Extrovis Ag Trabectedin composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
DE3923985C1 (cs) * 1989-07-20 1990-06-28 Daimler-Benz Aktiengesellschaft, 7000 Stuttgart, De
GB2252781B (en) * 1991-02-14 1994-08-17 Sanwa Shutter Corp Architectural shutter curtain device
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins

Also Published As

Publication number Publication date
NZ334704A (en) 2000-09-29
DE69719201D1 (de) 2003-03-27
ATE232868T1 (de) 2003-03-15
PT931083E (pt) 2003-07-31
CA2266081A1 (en) 1998-03-26
NO991301L (no) 1999-05-14
CZ91499A3 (cs) 1999-08-11
HUP0000068A3 (en) 2001-12-28
US5721362A (en) 1998-02-24
IL128993A (en) 2006-06-11
PL188572B1 (pl) 2005-02-28
KR100358832B1 (ko) 2002-11-21
EP0931083A4 (en) 2000-05-24
JP4425995B2 (ja) 2010-03-03
EP0931083B1 (en) 2003-02-19
AU738282B2 (en) 2001-09-13
RU2194709C2 (ru) 2002-12-20
ES2192273T3 (es) 2003-10-01
NO991301D0 (no) 1999-03-17
NO325345B1 (no) 2008-04-07
BR9712073A (pt) 2002-01-15
CZ299596B6 (cs) 2008-09-17
HUP0000068A2 (hu) 2000-06-28
DK0931083T3 (da) 2003-05-26
EP0931083A1 (en) 1999-07-28
CA2266081C (en) 2006-12-12
AU4420597A (en) 1998-04-14
DE69719201T2 (de) 2003-12-11
KR20000036242A (ko) 2000-06-26
WO1998012198A1 (en) 1998-03-26
JP2001501196A (ja) 2001-01-30
CN1237974A (zh) 1999-12-08
PL332206A1 (en) 1999-08-30
HU229407B1 (en) 2013-12-30
BR9712073B1 (pt) 2013-06-18
CN1096463C (zh) 2002-12-18

Similar Documents

Publication Publication Date Title
IL128993A0 (en) A method for producing ecteinascidin compounds pharmaceutical compositions containing same and use thereof
MY121760A (en) Benzothiazin and benzoxazin derivatives;their preparation and uses
MX9707706A (es) Compuestos intermediarios novedosos y proceso para la manufactura de derivados de la camptotecina (cpt-11) y compuestos relacionados.
NZ504106A (en) Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
UA27728C2 (uk) Похідні піразолу, що мають спорідненість до рецепторів канабіноїдів, спосіб їх одержання, фармацевтична композиція та проміжна сполука
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
GR3024420T3 (en) Process for the preparation of oxetanones
ZA951227B (en) Camptothecin derivatives and process for their preparation
HU9401974D0 (en) New intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
BG105925A (en) Novel tricyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
BG106932A (en) Novel compounds having hypolipedemic and hypocholesteremic activities, processes for their preparation and pharmaceutical compositions containing them
YU75101A (sh) Supstituisani biciklični heterocikli, postupak njihove izrade i njihova upotreba kao antigojaznih i hipoholesterolemijskih agenasa
DK0579770T3 (da) Makrocycliske lactamprokinetika
AU1198897A (en) 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists
UA72883C2 (uk) Біциклічна сполука, способи її одержання, фармацевтичні композиції, що її містять,способи лікування та попередження різних захворювань, проміжні сполуки та способи їх одержання
IL160820A0 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
GR3030506T3 (en) 1-azaadamantane derivatives as 5-ht agonists or antagonists.
HUT39147A (en) Process for preparing phenoxy-propanol-acethylene derivatives and pharmaceutical compositions containing such compounds
EP0828749A4 (en) Compositions and methods for the synthesis of organophosphorus derivatives
DE3461281D1 (en) +/- 2-((3,4-methylenedioxy)phenethyl)-5-((3-carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidines, pharmaceutical compositions containing them, process for their production and intermediates therefor
MY131832A (en) New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed